UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Diabetes care, 2015-10, Vol.38 (10), p.1964-1974

2015

Volltextzugriff (PDF)

Adult-Onset Type 1 Diabetes: Current Understanding and Challenges

Diabetes care, 2021-11, Vol.44 (11), p.2449-2456

2021

Volltextzugriff (PDF)

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets

Frontiers in immunology, 2021-04, Vol.12, p.667989

2021

Volltextzugriff (PDF)

Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories

Nature communications, 2022-03, Vol.13 (1), p.1514-1514, Article 1514

2022

Volltextzugriff (PDF)

Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity

Diabetes care, 2023-10, Vol.46 (10), p.1753-1761

2023

Volltextzugriff (PDF)

Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S

Diabetes care, 2021-10, Vol.44 (10), p.2269-2276

2021

Volltextzugriff (PDF)

668-P: Exploring Attitudes toward Autoantibody Screening in People Living with T1D, Caregivers, and First-Degree Relatives

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes

Diabetologia, 2019-05, Vol.62 (5), p.744-753

2019

Volltextzugriff (PDF)

Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study

The lancet. Diabetes & endocrinology, 2022-08, Vol.10 (8), p.589-596

2022

Volltextzugriff (PDF)

The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence

Diabetes care, 2021-08, Vol.44 (8), p.1734-1743

2021

Volltextzugriff (PDF)

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

Diabetologia, 2023-03, Vol.66 (3), p.415-424

2023

Volltextzugriff (PDF)

The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence

Diabetes (New York, N.Y.), 2021-08, Vol.70 (8), p.1623-1633

2021

Volltextzugriff (PDF)

634-P: Autoantibody Screening Attitudes and Experiences in People Affected by Type 1 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Erratum. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743

Diabetes care, 2022-06, Vol.45 (6), p.1491-1491

2022

Volltextzugriff (PDF)

37-OR: Childhood Screening and Interception Strategies: An Economic Cohort Simulation Model

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Erratum. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes 2021;70:1623-1633

Diabetes (New York, N.Y.), 2022-06, Vol.71 (6), p.1371-1371

2022

Volltextzugriff (PDF)

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Diabetes care, 2023-03, Vol.46 (3), p.526-534

2023

Volltextzugriff (PDF)

Response to Comment on Dunne et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743

Diabetes care, 2022-05, Vol.45 (5), p.e99-e99

2022

Volltextzugriff (PDF)

JDRF's vision and strategy for prevention of type 1 diabetes

Pediatric diabetes, 2016-07, Vol.17 (S22), p.87-92

2016

Volltextzugriff (PDF)

Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?

Diabetes (New York, N.Y.), 2012-08, Vol.61 (8), p.1907-1914

2012

Volltextzugriff (PDF)

1690-P: Predicting Onset of Type 1 Diabetes Using a Novel Interaction Model

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Parent and Pediatrician Preferences for Type 1 Diabetes Screening in the U.S

Diabetes care, 2021-02, Vol.44 (2), p.332-339

2021

Volltextzugriff (PDF)

342-OR: Optimal Ages for Screening for T1D Risk in Children

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

248-OR: Visualizing Heterogeneous Islet Autoantibody Trajectories of Children Who Develop T1D from Multisite Birth Cohort Studies

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

211-OR: Analysis of Longitudinal Autoantibody Profiles and the Progression Rates to Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(115)
Dissertationen
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(16)
Diabetes Care
(10)
Shock
(5)
The Journal Of Immunology
(4)
Diabetologia
(3)
Nature
(3)
Plos One
(3)
The journal Of Immunology/the journal Of Immunology
(3)
Amia ... Annual Symposium Proceedings
(2)
Bioscience
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Adult-Onset Type 1 Diabetes: Current Understanding and Challenges

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets

Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories

Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity

Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S

668-P: Exploring Attitudes toward Autoantibody Screening in People Living with T1D, Caregivers, and First-Degree Relatives

Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes

Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study

The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence

634-P: Autoantibody Screening Attitudes and Experiences in People Affected by Type 1 Diabetes

Erratum. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743

37-OR: Childhood Screening and Interception Strategies: An Economic Cohort Simulation Model

Erratum. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes 2021;70:1623-1633

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Response to Comment on Dunne et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743

JDRF's vision and strategy for prevention of type 1 diabetes

Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?

1690-P: Predicting Onset of Type 1 Diabetes Using a Novel Interaction Model

Parent and Pediatrician Preferences for Type 1 Diabetes Screening in the U.S

342-OR: Optimal Ages for Screening for T1D Risk in Children

248-OR: Visualizing Heterogeneous Islet Autoantibody Trajectories of Children Who Develop T1D from Multisite Birth Cohort Studies

211-OR: Analysis of Longitudinal Autoantibody Profiles and the Progression Rates to Type 1 Diabetes

Suchergebnisse filtern